HIV Pharmacy Specialty Residency Program
This 12-month program for advanced degree pharmacists will provide the resident with experience in a variety of HIV clinical settings, with a focus on ambulatory care (other rotations include inpatient services, community pharmacy, family practice clinics, drug information/marketing, pediatrics, therapeutic drug monitoring, consulting, community AIDS groups, and infectious diseases). The resident will be expected to initiate and complete a research project. The resident will also have teaching responsibilities for B.Sc.Phm. / M.Sc. hospital residents and Pharm.D. candidates doing elective HIV ambulatory rotations.
Please review the HIV Residency Program Manual for more detailed information on the program.
The primary preceptors are Alice Tseng, Pharm.D., University Health Network, Assistant Professor, Faculty of Pharmacy, University of Toronto, and Nancy Sheehan, B.Pharm, M.Sc., McGill University Health Centre, Assistant Clinical Professor, Faculty of Pharmacy, University of Montréal. The Immunodeficiency Clinic, University Health Network in Toronto, and Immunodeficiency Service, McGill University Health Centre in Montreal, are 2 of the largest, university-affiliated, outpatient HIV clinics in Canada, serving together over 2500 patients per year. Primary and specialty care is provided through a comprehensive interdisciplinary approach (including medicine, pharmacy, nursing, social work, nutrition, and psychology). Other priorities include clinical research, outreach programs, and antiretroviral therapeutic drug monitoring.
Applicants should possess a Pharm.D. or M.Sc.Phm. degree (or equivalent experience) and have completed a CSHP- or ASHP-accredited (PGY1) residency program. The desired starting date is July-August of each year. The option to complete a 2 year combined Residency/Master`s program is also available. Upon completion of this program, the resident will be awarded both a Specialty Residency Certificate and a M.Sc.Phm. degree from the University of Toronto.
Funding for the HIV Pharmacy Specialty Residency has been provided through unrestricted educational grants from Gilead Sciences Canada Inc. and Merck Frosst Canada Inc.
Interested applicants should send a cover letter describing their interest, a curriculum vitae, and two letters of reference before March 1st to both:
Toronto General Hospital, 13N-1314
585 University Avenue
Toronto, Ontario, M5G 2N2
phone: (416) 340-4800, ext. 8763
fax: (416) 340-4890
Québec antiretroviral therapeutic
drug monitoring program
McGill University Health Centre
1001, boul. Décarie, C.RC-6004
Montréal, Québec H4A 3J1
Phone: 514-934-1934 x 32169
The HIV Pharmacy Speciality Residency is a joint program of the University Health Network and McGill University Health Centre, in conjunction with the Leslie Dan Faculty of Pharmacy, University of Toronto.
HIV Residency Program Manual
Tseng A, Foisy M, Bajcar J, Musing E, Wells J, Grondin M, Salit I.
Development of an HIV Pharmacy Practice Specialty Residency (Article)
Am J Health-Syst Pharm 2001;58:591